Citigroup’s Avalon GloboCare ALBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-131
Closed -$312 6032
2025
Q3
$312 Sell
131
-820
-86% -$1.96K ﹤0.01% 5741
2025
Q2
$2.64K Buy
+951
New +$3.42K ﹤0.01% 5340
2021
Q2
Sell
-9
Closed -$1K 6100
2021
Q1
$1K Sell
9
-17
-65% -$3.19K ﹤0.01% 6081
2020
Q4
$4K Buy
26
+20
+333% +$3.56K ﹤0.01% 7138
2020
Q3
$1K Sell
6
-12
-67% -$2.74K ﹤0.01% 7348
2020
Q2
$5K Sell
18
-23
-56% -$5.62K ﹤0.01% 7251
2020
Q1
$10K Buy
41
+12
+41% +$2.74K ﹤0.01% 7033
2019
Q4
$8K Buy
29
+22
+314% +$5.5K ﹤0.01% 7256
2019
Q3
$2K Sell
7
-33
-83% -$10.4K ﹤0.01% 7518
2019
Q2
$16K Sell
40
-20
-33% -$9.04K ﹤0.01% 7156
2019
Q1
$49K Buy
+60
New +$40.1K ﹤0.01% 6350

Other funds holding ALBT

Citigroup's ALBT Position: Q4 2025 in Review

Citigroup sold out of Avalon GloboCare (ALBT) in Q4 2025, closing a stake of 131 shares — an estimated $312 sold.

Citigroup first reported a position in ALBT in Q1 2019 and held it in 11 quarters. The position peaked at $49K in Q1 2019. 14 funds tracked by Wall St. Rank hold ALBT as of Q4 2025.

  • Citigroup reported no remaining Avalon GloboCare position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 131 Avalon GloboCare shares in Q4 2025, an estimated $312.
  • Citigroup first reported a position in Avalon GloboCare in Q1 2019 and held it in 11 quarters.
  • Citigroup's Avalon GloboCare position peaked at $49K in Q1 2019.
  • 14 funds tracked by Wall St. Rank held Avalon GloboCare as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.